Sirion Holdings

About:

Sirion Holdings, Inc., through its subsidiaries, engages in the research, discovery, development, and commercialization of pharmaceutical

Description:

Sirion Holdings, Inc., through its subsidiaries, engages in the research, discovery, development, and commercialization of pharmaceutical products and medical devices for the ophthalmic market. Its products are used to treat various sight threatening and debilitating eye diseases and conditions, including those that affect the back of the eye.In addition, it offers contract services, including clinical, regulatory, consulting, and medical education services focused on ophthalmology to pharmaceutical companies developing products with ophthalmic indications and to others involved in the ophthalmic area. Sirion Holdings, Inc. was incorporated in 2006 and is based in Tampa, Florida.

Total Funding Amount:

$29.2M

Headquarters Location:

Tampa, Florida, United States

Founded Date:

2006-01-01

Founders:

Barry Butler, Philippe Boulangeat, Roger Vogel, Susan Benton

Number of Employees:

11-50

Last Funding Date:

2009-10-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai